These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22498638)

  • 1. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
    Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
    J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
    Mollard S; Lurienne L; Heimann SM; Bandinelli PA
    J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic healthcare costs of Clostridium difficile infection: a systematic review.
    Ghantoji SS; Sail K; Lairson DR; DuPont HL; Garey KW
    J Hosp Infect; 2010 Apr; 74(4):309-18. PubMed ID: 20153547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
    Mehrotra P; Jang J; Gidengil C; Sandora TJ
    Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of Clostridium difficile infection: understanding the healthcare burden.
    Bouza E
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():5-12. PubMed ID: 23121549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
    J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Clostridium difficile Infection in European Countries.
    Reigadas Ramírez E; Bouza ES
    Adv Exp Med Biol; 2018; 1050():1-12. PubMed ID: 29383660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
    Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.
    Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD
    Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
    Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
    Kunishima H; Ito K; Laurent T; Abe M
    J Infect Chemother; 2018 Nov; 24(11):892-901. PubMed ID: 30190105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
    Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
    van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
    J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.